Cercar
01/04/2026
Infection and inflammation of the seminal tract: a review of its relationship to male fertility
Suñé, AV, Cosentino, M. Infection and inflammation of the seminal tract: a review of its relationship to male fertility. Actas Urologicas Espanolas. 2026; 50(3)DOI:10.1016/j.acuro.2025.501899. PMID:. IF:1.200(Q3/7D).
01/01/2022
Hemolytic Anemia After Surgical Mitral Valve Repair Treated With Transcatheter Edge-to-Edge Device
Ruiz-López A., Li C.-H.P., Valdovinos P., Rodríguez Á., Bonet A., Tauron M., Ligero C., Millan X., Alegret J.M., Viladés D., Arzamendi D.. Hemolytic Anemia After Surgical Mitral Valve Repair Treated With Transcatheter Edge-to-Edge Device. JACC. Case reports. 2022; 4(12)DOI:10.1016/j.jaccas.2022.03.021. PMID:. IF:(Q/D).
12/05/2024
Prevalence and prognostic significance of malnutrition in patients with secondary mitral regurgitation undergoing transcatheter edge-to-edge repair
Pezzola, E, Tomasoni, D, Caneiro-Queija, B, Raposeiras-Roubin, S, Freixa, X, Arzamendi, D, Benito-González, T, Montefusco, A, Pascual, I, Nombela-Franco, L, Rodes-Cabau, J, Shuvy, M, Portolés-Hernández, A, Godino, C, Haberman, D, Metra, M, Estévez-Loureiro, R, Adamo, M. Prevalence and prognostic significance of malnutrition in patients with secondary mitral regurgitation undergoing transcatheter edge-to-edge repair. CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS. 2024; 104(2)DOI:10.1002/ccd.31079. PMID:38736245. IF:2.100(Q3/6D).
01/10/2024
Treatment of functionally nonsignificant vulnerable plaques in multivessel STEMI: design of the VULNERABLE trial
Gomez-Lara, J, Lopez-Palop, R, Rumiz, E, Jurado-Roman, A, Gomez-Menchero, A, Valencia, J, Fernandez, E, Ramirez, LRG, Brugaletta, S, Millan, R, Cortes, C, Tejedor, P, Gutierrez-Barrios, A, Flores, X, Cid-alvarez, AB, Garcia-Blas, S, Garcia-Camarero, T, Vicente, JAL, Vaquerizo, B, Soriano, JGC, Caballero, J, Piris, RMC, Sanchez-Elvira, G, Oyarzabal, L, Pernigotti, A, Tramullas, A, Antuna, P, Rodriguez-Leor, O, Ojeda, S, Rossello, X, Gomez-Hospital, JA, Bermejo, J, Garcia-Garcia, HM, Prado, APD, Gutierrez-Ibanes, E. Treatment of functionally nonsignificant vulnerable plaques in multivessel STEMI: design of the VULNERABLE trial. REC, interventional cardiology. 2024; 6(4)DOI:10.24875/RECIC.M24000468. PMID:. IF:(Q/D).
17/02/2026
Frequency and Prognostic Significance of ESR1 Mutations Post-CDK4/6 inhibitors in ER+/HER2# Metastatic Breast Cancer: Real-World Data from the GEICAM_RegistEM Study
Guerrero-Zotano, A, Antolin, S, Martorell, AT, Cruz-Jurado, J, Andres, R, Saura, S, Rodriguez-Sanchez, C, Galve, E, Falo, C, Margeli-Vila, M, Rodriguez-Lescure, A, Miguel, A, Chacon, J, Adrover-Cebrian, E, Corbellas-Aparicio, M, Marin-Alcala, M, Gonzalez-Maeso, I, Varela-Ferreiro, S, Arqueros, C, Anton-Torres, A, Servitja, S, Moreno-Munoz, D, Merino, M, Ballesteros-Garcia, A, Echarri-Gonzalez, M, Alonso-Romero, J, Seijas, TR, Iranzo-Cruz, V, De la Haba-Rodriguez, J, Guerra, J, Palomar, AL, Illarramendi, MJ, Ortiz, AG, Garcia-Palomo, A, Ruiz-Borrego, M, Villanueva, R, Zazo, S, Jerez-Gilarranz, Y, Rendo, CR, Lizarraga, NA, Ceballos-Lenza, I, Murillo, JL, Figuero, L, Herranz, J, Martin, N, Fernandez-Garcia, D, Lopez, IA, Lopez-Tarruella, S, Todo, FR. Frequency and Prognostic Significance of ESR1 Mutations Post-CDK4/6 inhibitors in ER+/HER2# Metastatic Breast Cancer: Real-World Data from the GEICAM_RegistEM Study. CLINICAL CANCER RESEARCH. 2026; 32DOI:. PMID:. IF:10.200(Q1/1D).
01/03/2026
Impact of Preprocedural Anemia on Outcomes in Patients With Tricuspid Regurgitation Undergoing Transcatheter Edge-to-Edge Repair: Insights From the TRISPA Registry
Echarte-Morales, J, Ruberti, A, Sanchis, L, Arzamendi, D, Moñivas, V, Carrasco-Chinchilla, FC, Pan, MN, Nombela-Franco, L, Pascual, I, Benito-González, T, Pérez, R, Gómez-Blázquez, I, Amat-Santos, IJ, Cruz-González, I, Sánchez-Recalde, A, Alvarez, ABC, Barreiro-Pérez, M, Umanzor, EF, Li, CH, Trigo, MD, Martínez-Carmona, JD, Mesa, D, Jiménez, P, Cepas-Guillén, P, Avanzas, P, Fernandez-Vázquez, F, Freixa, X, Estévez-Loureiro, R. Impact of Preprocedural Anemia on Outcomes in Patients With Tricuspid Regurgitation Undergoing Transcatheter Edge-to-Edge Repair: Insights From the TRISPA Registry. CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS. 2026; 107(4)DOI:10.1002/ccd.70408. PMID:41398453. IF:2.100(Q3/6D).
01/02/2026
Genetic anticipation and cardiac conduction abnormalities in myotonic dystrophy type 1: implications for early stratification from a multicenter registry
Lorca, R, Alen, A, Moliner-Abos, C, de Frutos, F, Báez-Ferrer, N, Peña-Peña, ML, Villacorta, E, Ripoll-Vera, T, Zorio, E, Martínez-Gimeno, A, Bermudez-Jiménez, J, Limeres, J, Tiron, C, Larrañaga-Moreira, JM, Cabrera-Romero, E, García-Pavia, P, Espinosa, MA, Piqueras, J, García-Hernández, S, Palomino-Doza, J, Soriano-Amores, M, Moris, G, Carrillo-Mora, LM, Syris, P, Alvarez-Velasco, R, Gimeno, JR, Muñoz, C. Genetic anticipation and cardiac conduction abnormalities in myotonic dystrophy type 1: implications for early stratification from a multicenter registry. Ijc Heart & Vasculature. 2026; 62DOI:10.1016/j.ijcha.2025.101851. PMID:41488597. IF:(Q/D).
01/03/2026
Characterization of hepatic, portal, and renal venous flow patterns by Doppler ultrasound across tricuspid regurgitation grades
Rodriguez-Pérez, A, Moliner-Abos, C, Viladés-Medel, D, Fernández-Martinez, J, Mayol-Domingo, J, Ruiz-Lopez, A, Salido, M, Descalzo, M, Pujadas-Olano, S, Menduiña, I, Bos-Real, L, Parada-Barcia, JA, Barreiro-Pérez, M, Forado-Benatar, I, Arenas-Loriente, A, Leta-Petracca, R, Arzamendi, D, Lic, CHP. Characterization of hepatic, portal, and renal venous flow patterns by Doppler ultrasound across tricuspid regurgitation grades. REVISTA ESPANOLA DE CARDIOLOGIA. 2026; 79(3)DOI:10.1016/j.rec.2025.08.002. PMID:40907823. IF:4.900(Q1/2D).
17/02/2026
Long-term response Patterns in HER2-positive advanced breast cancer within the geicam/2014-03 (registem) study
Alvarez, I, Guerrero-Zotano, A, Cruz-Jurado, J, Antol n, S, Galve, E, Rodr guez, C, Hern ndez, M, Tibau, A, Falo, C, Chac n, J, Miguel, A, Rodr guez-Lescure, A, Adrover, E, Margel -Vila, M, Andr s, R, Servitja, S, Merino, M, Gonz lez, I, Alonso-Romero, J, Villanueva, R, Echarri, M, Ant n-Torres, A, Varela, S, Ru z-Borrego, M, Guerra, J, Corbellas, M, Escudero, M, Bezares, S, Rojo, F, L pez-Tarruella, S. Long-term response Patterns in HER2-positive advanced breast cancer within the geicam/2014-03 (registem) study. CLINICAL CANCER RESEARCH. 2026; 32DOI:. PMID:. IF:10.200(Q1/1D).
04/02/2026
Immunological Biomarkers to Assess Activity and Treatment Response in IgG4-Related Disease
Moya-Alvarado, P, Lopez-Gomez, M, Martínez-Martinez, L, Park, HS, Leyva, TF, Martín, MC, Codes-Mendez, H, Lacruz, AC, Calleja, S, Magallares, B, Castellví, I, Barros-Membrilla, AJ, Bernárdez, J, Corominas, H. Immunological Biomarkers to Assess Activity and Treatment Response in IgG4-Related Disease. Medicina-Lithuania. 2026; 62(2)DOI:10.3390/medicina62020323. PMID:41752722. IF:2.400(Q1/3D).
01/02/2026
Urinary sodium to guide diuretic therapy in acute heart failure: results of a national survey
Marcos, MC, Trullàs, JC, Perez-Silvestre, J, Miró, O, Quiroga, B, Mirabet, S, Romero-González, G. Urinary sodium to guide diuretic therapy in acute heart failure: results of a national survey. ESC Heart Failure. 2026; 13(1)DOI:10.1093/eschf/xvag006. PMID:41711714. IF:3.700(Q1/3D).
01/03/2026
Does Biological Sex Determine the Natural History and Management of Infective Endocarditis?
Grillo, S, Isler, B, Bonet-Basiero, A, Roselló-Díez, E, Escolà-Vergé, L. Does Biological Sex Determine the Natural History and Management of Infective Endocarditis?. CANADIAN JOURNAL OF CARDIOLOGY. 2026; 42(3)DOI:10.1016/j.cjca.2025.10.041. PMID:41197950. IF:5.300(Q1/2D).
06/02/2026
Use of anti-nucleocapsid antibody detection as a marker of SARS-CoV-2 infection in healthcare professionals: a longitudinal seroprevalence study at a university hospital in Catalonia, Spain
Micó, M, Trapé, J, González-García, L, Trujillo-Isern, G, González-Fernández, C, López-Madueño, J, Bérgamo, S, Pérez-Vidal, R, Flor, A, Martínez-Montero, R, Rives, J, Arnau, A, Fàbrega, A. Use of anti-nucleocapsid antibody detection as a marker of SARS-CoV-2 infection in healthcare professionals: a longitudinal seroprevalence study at a university hospital in Catalonia, Spain. BMC INFECTIOUS DISEASES. 2026; 26(1)DOI:10.1186/s12879-026-12796-8. PMID:41652586. IF:3.000(Q2/4D).
17/04/2026
N-terminal proBNP adds prognostic value to high-sensitivity cardiac troponin I in elective thoracic surgery: an observational cohort study
Alonso, M, Popova, E, De Miguel, M, García-Osuna, A, Gonzalez-Tallada, A, Ordoñez-Llanos, J, Jauregui, A, Trujillo, JC, Grande, AM, Martínez-Téllez, E, Parera, A, Planas, G, Trujillo, L, Butron, D, Solà-Roca, J, De Nadal, M. N-terminal proBNP adds prognostic value to high-sensitivity cardiac troponin I in elective thoracic surgery: an observational cohort study. BMJ Open. 2026; 16(4)DOI:10.1136/bmjopen-2025-108073. PMID:41997702. IF:2.300(Q2/3D).
07/04/2026
Altered small dense LDL profiles in long-standing controlled type 1 diabetes
Sardà, H, Solé, A, Colom, C, Borràs, C, Carreras, G, Benítez, S, Miñambres, I, Escolà-Gil, JC, Sánchez-Quesada, JL, Pérez, A. Altered small dense LDL profiles in long-standing controlled type 1 diabetes. Frontiers in Endocrinology. 2026; 17DOI:10.3389/fendo.2026.1804987. PMID:42022901. IF:4.600(Q1/3D).
27/04/2026
Why does LDL-C follow a different paradigm from other endocrine-metabolic diseases in cardiovascular prevention?
Sánchez-Quesada, JL, Pérez, A. Why does LDL-C follow a different paradigm from other endocrine-metabolic diseases in cardiovascular prevention?. Frontiers in Endocrinology. 2026; 17DOI:10.3389/fendo.2026.1813342. PMID:42125229. IF:4.600(Q1/3D).
20/01/2026
Cardiovascular biomarkers and preeclampsia: A narrative review
Ullmo, J, Nan, MN, Cruz-Lemini, M, Garrido-Gimenez, C, Platero, J, García-Osuna, A, García-Manau, P, Twickler, M, Llurba, E. Cardiovascular biomarkers and preeclampsia: A narrative review. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION. 2026; 56(1)DOI:10.1111/eci.70123. PMID:41059676. IF:3.600(Q1/2D).
01/10/2024
PCSK9 Antibodies Treatment Specifically Enhances the Macrophage-specific Reverse Cholesterol Transport Pathway in Heterozygous Familial Hypercholesterolemia.
Borràs C, Canyelles M, Girona J, Ibarretxe D, Santos D, Revilla G, Llorente-Cortes V, Rotllan N, Kovanen PT, Jauhiainen M, Lee-Rueckert M, Masana L, Arrieta F, Martínez-Botas J, Gómez-Coronado D, Ribalta J, Tondo M, Blanco-Vaca F, Escolà-Gil JC. PCSK9 Antibodies Treatment Specifically Enhances the Macrophage-specific Reverse Cholesterol Transport Pathway in Heterozygous Familial Hypercholesterolemia.. Jacc-Basic To Translational Science. 2024; 9(10)DOI:10.1016/j.jacbts.2024.06.008. PMID:39534644. IF:(Q/D).
01/08/2024
Exploring Plasma Coenzyme Q10 Status in Paediatric Dyslipidaemia
Minguez, B, de Los Santos, M, Garcia-Volpe, C, Molera, C, Paredes-Fuentes, AJ, Oliva, C, Arias, A, Rodriguez-Gonzalez, H, Yubero, D, Tondo, M, Santos-Ocaña, C, Meavilla, S, Artuch, R. Exploring Plasma Coenzyme Q10 Status in Paediatric Dyslipidaemia. Antioxidants. 2024; 13(8)DOI:10.3390/antiox13080966. PMID:39199213. IF:6.600(Q1/1D).
01/05/2026
Effects of zibotentan and dapagliflozin combined in patients with compensated cirrhosis: A randomized placebo-controlled exploratory study
Garcia-Pagan, JC, Gluud, LL, Mandorfer, M, Schattenberg, JM, De Gottardi, A, Berzigotti, A, Fortea, JI, Martínez, AA, Alvarado-Tapias, E, Berning, M, Petryszyn, P, Henricson, E, Berglind, N, Lin, M, Persson, K, Mercier, A, Ambery, P, Bosch, J, Oscarsson, J, Rockey, DC. Effects of zibotentan and dapagliflozin combined in patients with compensated cirrhosis: A randomized placebo-controlled exploratory study. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY. 2026; 92(5)DOI:10.1002/bcp.70332. PMID:41362018. IF:3.000(Q2/4D).